UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Biology and Management of Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma, and Malignant Peripheral Nerve Sheath Tumors: State of the Art and Perspectives

Journal of clinical oncology, 2018-01, Vol.36 (2), p.160-167

2018

Volltextzugriff (PDF)

Activity of Selumetinib in Neurofibromatosis Type 1–Related Plexiform Neurofibromas

The New England journal of medicine, 2016-12, Vol.375 (26), p.2550-2560

2016

Volltextzugriff (PDF)

Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma

Cancer cell, 2017-06, Vol.31 (6), p.833-843.e5

2017

Volltextzugriff (PDF)

Understanding and Managing Methotrexate Nephrotoxicity

The oncologist (Dayton, Ohio), 2006-06, Vol.11 (6), p.694-703

2006

Volltextzugriff (PDF)

Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study

PLoS medicine, 2021-08, Vol.18 (8), p.e1003734

2021

Volltextzugriff (PDF)

Sirolimus for progressive neurofibromatosis type 1-associated plexiform neurofibromas: a neurofibromatosis Clinical Trials Consortium phase II study

Neuro-oncology (Charlottesville, Va.), 2015-04, Vol.17 (4), p.596-603

2015

Volltextzugriff (PDF)

Current status of sporadic and neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors

Current oncology reports, 2009-07, Vol.11 (4), p.322-328

Widemann, Brigitte C.

2009

Volltextzugriff (PDF)

The characteristics of 76 atypical neurofibromas as precursors to neurofibromatosis 1 associated malignant peripheral nerve sheath tumors

Neuro-oncology (Charlottesville, Va.), 2018-05, Vol.20 (6), p.818-825

2018

Volltextzugriff (PDF)

Longitudinal evaluation of peripheral nerve sheath tumors in neurofibromatosis type 1: growth analysis of plexiform neurofibromas and distinct nodular lesions

Neuro-oncology (Charlottesville, Va.), 2020-09, Vol.22 (9), p.1368-1378

2020

Volltextzugriff (PDF)

Neurofibromatosis Type 1-Associated MPNST State of the Science: Outlining a Research Agenda for the Future

JNCI : Journal of the National Cancer Institute, 2017-08, Vol.109 (8)

2017

Volltextzugriff (PDF)

Management of neurofibromatosis type 1-associated plexiform neurofibromas

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (11), p.1827-1844

2022

Volltextzugriff (PDF)

Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2-Associated Vestibular Schwannomas

Journal of clinical oncology, 2016-05, Vol.34 (14), p.1669-1675

2016

Volltextzugriff (PDF)

Longitudinal association between executive function and academic achievement in children with neurofibromatosis type 1 and plexiform neurofibromas

Journal of the International Neuropsychological Society, 2023-11, Vol.29 (9), p.839-849

2023

Volltextzugriff (PDF)

Association of plexiform neurofibroma volume changes and development of clinical morbidities in neurofibromatosis 1

Neuro-oncology (Charlottesville, Va.), 2018-11, Vol.20 (12), p.1643-1651

2018

Volltextzugriff (PDF)

Safe marginal resection of atypical neurofibromas in neurofibromatosis type 1

Journal of neurosurgery, 2020-11, Vol.133 (5), p.1516-1526

2020

Volltextzugriff (PDF)

Development and psychometric testing of a pediatric chronic graft-versus-host disease symptom scale: protocol for a two-phase, mixed methods study

Frontiers in psychology, 2024-01, Vol.14, p.1243005

2024

Volltextzugriff (PDF)

Recommendations for imaging tumor response in neurofibromatosis clinical trials

Neurology, 2013-11, Vol.81 (21 Suppl 1), p.S33

2013

Volltextzugriff (PDF)

Advances, challenges and progress in pediatric hematology and oncology

Current opinion in pediatrics, 2023-02, Vol.35 (1), p.39-40

Widemann, Brigitte C

2023

Volltextzugriff (PDF)

Glucarpidase, Leucovorin, and Thymidine for High-Dose Methotrexate-Induced Renal Dysfunction: Clinical and Pharmacologic Factors Affecting Outcome

Journal of clinical oncology, 2010-09, Vol.28 (25), p.3979-3986

2010

Volltextzugriff (PDF)

Malignant Peripheral Nerve Sheath Tumors State of the Science: Leveraging Clinical and Biological Insights into Effective Therapies

Complexity (New York, N.Y.), 2017, Vol.2017 (2017), p.1-10-015

2017

Volltextzugriff (PDF)

The primacy of NF1 loss as the driver of tumorigenesis in neurofibromatosis type 1-associated plexiform neurofibromas

Oncogene, 2017-06, Vol.36 (22), p.3168-3177

2017

Volltextzugriff (PDF)

Sirolimus for non-progressive NF1-associated plexiform neurofibromas: An NF clinical trials consortium phase II study

Pediatric blood & cancer, 2014-06, Vol.61 (6), p.982-986

2014

Volltextzugriff (PDF)

Phase I Trial and Pharmacokinetic Study of Lexatumumab in Pediatric Patients With Solid Tumors

Journal of clinical oncology, 2012-11, Vol.30 (33), p.4141-4147

2012

Volltextzugriff (PDF)

Pediatric adrenocortical carcinoma

Frontiers in endocrinology (Lausanne), 2022-10, Vol.13, p.961650-961650

2022

Volltextzugriff (PDF)

Targeting Refractory Sarcomas and Malignant Peripheral Nerve Sheath Tumors in a Phase I/II Study of Sirolimus in Combination with Ganetespib (SARC023)

Complexity (New York, N.Y.), 2020, Vol.2020 (2020), p.1-8

2020

Volltextzugriff (PDF)

1 – 25 von 497

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(430)
Mit Volltextzugriff
(407)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Biology and Management of Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma, and Malignant Peripheral Nerve Sheath Tumors: State of the Art and Perspectives

Activity of Selumetinib in Neurofibromatosis Type 1–Related Plexiform Neurofibromas

Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma

Understanding and Managing Methotrexate Nephrotoxicity

Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study

Sirolimus for progressive neurofibromatosis type 1-associated plexiform neurofibromas: a neurofibromatosis Clinical Trials Consortium phase II study

Current status of sporadic and neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors

The characteristics of 76 atypical neurofibromas as precursors to neurofibromatosis 1 associated malignant peripheral nerve sheath tumors

Longitudinal evaluation of peripheral nerve sheath tumors in neurofibromatosis type 1: growth analysis of plexiform neurofibromas and distinct nodular lesions

Neurofibromatosis Type 1-Associated MPNST State of the Science: Outlining a Research Agenda for the Future

Management of neurofibromatosis type 1-associated plexiform neurofibromas

Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2-Associated Vestibular Schwannomas

Longitudinal association between executive function and academic achievement in children with neurofibromatosis type 1 and plexiform neurofibromas

Association of plexiform neurofibroma volume changes and development of clinical morbidities in neurofibromatosis 1

Safe marginal resection of atypical neurofibromas in neurofibromatosis type 1

Development and psychometric testing of a pediatric chronic graft-versus-host disease symptom scale: protocol for a two-phase, mixed methods study

Recommendations for imaging tumor response in neurofibromatosis clinical trials

Advances, challenges and progress in pediatric hematology and oncology

Glucarpidase, Leucovorin, and Thymidine for High-Dose Methotrexate-Induced Renal Dysfunction: Clinical and Pharmacologic Factors Affecting Outcome

Malignant Peripheral Nerve Sheath Tumors State of the Science: Leveraging Clinical and Biological Insights into Effective Therapies

The primacy of NF1 loss as the driver of tumorigenesis in neurofibromatosis type 1-associated plexiform neurofibromas

Sirolimus for non-progressive NF1-associated plexiform neurofibromas: An NF clinical trials consortium phase II study

Phase I Trial and Pharmacokinetic Study of Lexatumumab in Pediatric Patients With Solid Tumors

Pediatric adrenocortical carcinoma

Targeting Refractory Sarcomas and Malignant Peripheral Nerve Sheath Tumors in a Phase I/II Study of Sirolimus in Combination with Ganetespib (SARC023)

Suchergebnisse filtern